Shots:
- Altaris has entered into a definitive agreement to acquire Simulations Plus, making it a privately held subsidiary of Altaris & delisting it from NASDAQ
- As per the deal, Altaris will acquire Simulations Plus in an all-cash transaction valued at $18.50/share, representing the total deal value of ~$375M; closing is expected in Q4’26
- At or around closing, Altaris plans to combine Simulations Plus with Chemical Computing Group, an existing Altaris portfolio company, with Simulations Plus’ headquarters remaining in Research Triangle Park, North Carolina, post-transaction
Ref: Businesswire | Image: Simulations Plus | Press Release
Related News: Merck Animal Health to Acquire TARGAN
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
